Allometric analysis of ciprofloxacin and enrofloxacin pharmacokinetics across species

被引:39
作者
Cox, SK [1 ]
Cottrell, MB
Smith, L
Papich, MG
Frazier, DL
Bartges, J
机构
[1] Univ Tennessee, Dept Comparat Med, Knoxville, TN 37996 USA
[2] N Carolina State Univ, Coll Vet Med, Raleigh, NC USA
[3] Univ Tennessee, Coll Vet Med, Dept Small Anim Clin Sci, Knoxville, TN USA
关键词
D O I
10.1111/j.1365-2885.2004.00560.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to examine the allometric analysis of ciprofloxacin and enrofloxacin using pharmacokinetic data from the literature. The pharmacokinetic parameters used were half-life, clearance and volume of distribution. Relationships between body weight and the pharmacokinetic parameter were based on the empirical formula Y = aW(b), where Y is half-life, clearance or volume of distribution, W the body weight and a is an allometric coefficient (intercept) that is constant for a given drug. The exponential term b is a proportionality constant that describes the relationship between the pharmacokinetic parameter of interest and body weight. A total of 21 different species of animals were studied. Results of the allometric analyses indicated similarity between clearance and volume of distribution as they related to body weight for both drugs. Results of the current analyses indicate it is possible to use allometry to predict pharmacokinetic variables of enrofloxacin or ciprofloxacin based on body size of species. This could provide information on appropriate doses of ciprofloxacin and enrofloxacin for all species.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 74 条
[21]   A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog [J].
Cester, CC ;
Toutain, PL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (10) :1148-1155
[22]   The disposition of five therapeutically important antimicrobial agents in llamas [J].
Christensen, JM ;
Smith, BB ;
Murdane, SB ;
Hollingshead, N .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1996, 19 (06) :431-438
[23]   COMBINATION EFFECTS OF CIPROFLOXACIN, CLINDAMYCIN, AND METRONIDAZOLE INTRAVENOUSLY IN VOLUNTEERS [J].
DEPPERMANN, KM ;
BOECKH, M ;
GRINEISEN, S ;
SHOKRY, F ;
BORNER, K ;
KOEPPE, P ;
KRASEMANN, C ;
WAGNER, J ;
LODE, H .
AMERICAN JOURNAL OF MEDICINE, 1989, 87 (5A) :S46-S48
[24]  
DUDLEY MN, 1987, AM J MED, V82, P363
[25]   EFFECT OF DOSE ON SERUM PHARMACOKINETICS OF INTRAVENOUS CIPROFLOXACIN WITH IDENTIFICATION AND CHARACTERIZATION OF EXTRAVASCULAR COMPARTMENTS USING NONCOMPARTMENTAL AND COMPARTMENTAL PHARMACOKINETIC MODELS [J].
DUDLEY, MN ;
ERICSON, J ;
ZINNER, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (11) :1782-1786
[26]  
Elmas M, 2001, CAN J VET RES, V65, P64
[27]  
GARCIA OH, 1999, J VET PHARMACOL THER, V22, P209
[28]   Phenylbutazone pharmacokinetics and bioavailability in the Dromedary camel (Camelus dromedarius) [J].
Kadir, A ;
Ali, BH ;
AlHadrami, G ;
Bashir, AK ;
Landoni, MF ;
Lees, P .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1997, 20 (01) :54-60
[29]  
Helmick KE, 1997, J ZOO WILDLIFE MED, V28, P43
[30]   Pharmacokinetics of enrofloxacin in newborn and one-week-old calves [J].
Kaartinen, L ;
Pyorala, S ;
Moilanen, M ;
Raisanen, S .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1997, 20 (06) :479-482